Distrust In Science Isn't New: We Mistook Silence For Trust

For decades, the scientific establishment assumed public silence signaled trust. A veteran physician now argues that silence was never trust—it was disengagement born of skepticism, fear, and lived experience. The real crisis isn't that distrust in science is rising; it's that we mistook absence for consent.

Dr. Lisa Fitzpatrick, a physician who has spent decades working in underserved communities, lays out this thesis in a new Forbes piece. She contends that medical and scientific institutions have historically equated a lack of vocal opposition with public confidence. In reality, many communities—particularly Black, Indigenous, and low-income populations—simply stopped engaging with a system that had repeatedly failed them. The silence, she explains, was not agreement but a quiet withdrawal.

Distrust in science is far from new. The Tuskegee syphilis study, forced sterilizations, and ongoing disparities in healthcare access have built a foundation of suspicion that spans generations. What has changed is the volume. The COVID-19 pandemic, vaccine mandates, and polarized public discourse have turned long-simmering doubts into open defiance. Yet the root cause remains the same: a lack of earned trust.

Fitzpatrick emphasizes that trust cannot be demanded or assumed. It must be built through consistent, transparent, and respectful engagement. She points to decades of community work where listening—not lecturing—was the first step. In her experience, people do not reject science wholesale; they reject science that ignores their context. When a physician asks about a patient's family, understands their economic constraints, and acknowledges historical wrongs, the door to trust begins to open.

The key insight is that silence is not a blank check. Institutions that conflate quietness with approval miss the warning signs of disengagement. Data from surveys show that while many Americans express faith in science in abstract terms, trust drops sharply when questions turn to specific areas like pharmaceutical companies, government health agencies, or new medical technologies. The gap between general and specific trust is where silence lives.

This analysis carries profound implications for public health. Vaccine hesitancy, clinical trial recruitment disparities, and resistance to health guidelines all stem from the same trust deficit. Experts argue that simply producing more data or fact-checking misinformation will not close the gap. Instead, what is needed is a shift in power: giving communities a genuine seat at the table in research design, policy development, and health communication.

Looking ahead, the path to rebuilding trust requires institutional humility. Medical schools are starting to teach cultural competency and community-based participatory research. Some health agencies are investing in long-term partnerships rather than quick information campaigns. But the real milestones will be measured in years, not months. Fitzpatrick’s message is clear: earning trust means hearing the silence and understanding what it truly says.